Assignment task: Hypothetically, you were developing a drug for duchenne muscular dystrophy. This drug is a monoclonal antibody that showed some toxicity in ph1. You would like to get the FDA's advice on what type of trial design would be required for pivotal. Please explain all of the potential applications you may complete for this product at this point in development as well as what type of meeting request you may submit to FDA and why.